Product Liability Litigation: 'Stand And Fight' Strategy Pays Off For Drug And Device Makers

04 Apr 2018
News

Brenda Sandburg @brendasandburg Brenda.Sandburg@informa.com

Executive Summary

Legal analytics company Lex Machina finds that manufacturers most often win at summary judgement stage; however, about 96% of cases settle or are resolved procedurally.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United States

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Policy Legal Issues

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS122844

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS122844

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Product Liability Litigation: 'Stand And Fight' Strategy Pays Off For Drug And Device Makers

News

Executive Summary

Related Content

Product Liability Litigation Playbook: Pros And Cons For Pharma

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert